Samuel C. Wadsworth
Chief Tech/Sci/R&D Officer presso ULTRAGENYX PHARMACEUTICAL INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Samuel C.
Wadsworth is an Independent Director at Precision BioSciences, Inc. and the Chief Scientific Officer at Ultragenyx Pharmaceutical, Inc. He previously worked as the Director of Molecular Biology at Genzyme Corp.
from 2010 to 2013 and as the Chief Scientific Officer at Dimension Therapeutics, Inc. from 2013 to 2017.
Wadsworth also held a position as Principal at Sanofi-Aventis U.S.
LLC.
He earned a doctorate degree from The University of Chicago and an undergraduate degree from Southern Illinois University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Samuel C. Wadsworth
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01/11/2017 |
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 06/11/2021 |
Precedenti posizioni note di Samuel C. Wadsworth
| Società | Posizione | Fine |
|---|---|---|
| DIMENSION THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/11/2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2013 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Formazione di Samuel C. Wadsworth
| The University of Chicago | Doctorate Degree |
| Southern Illinois University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Samuel C. Wadsworth
